IL137518A0 - Derivatives of 1,2,4-oxadiazolone - Google Patents

Derivatives of 1,2,4-oxadiazolone

Info

Publication number
IL137518A0
IL137518A0 IL13751899A IL13751899A IL137518A0 IL 137518 A0 IL137518 A0 IL 137518A0 IL 13751899 A IL13751899 A IL 13751899A IL 13751899 A IL13751899 A IL 13751899A IL 137518 A0 IL137518 A0 IL 137518A0
Authority
IL
Israel
Prior art keywords
oxadiazolone
derivatives
Prior art date
Application number
IL13751899A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL137518A0 publication Critical patent/IL137518A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL13751899A 1998-01-29 1999-01-15 Derivatives of 1,2,4-oxadiazolone IL137518A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7296698P 1998-01-29 1998-01-29
US10227498P 1998-09-29 1998-09-29
PCT/US1999/000910 WO1999038510A1 (en) 1998-01-29 1999-01-15 Derivatives of 1,3,4-oxadiazolone

Publications (1)

Publication Number Publication Date
IL137518A0 true IL137518A0 (en) 2001-07-24

Family

ID=26753969

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13751899A IL137518A0 (en) 1998-01-29 1999-01-15 Derivatives of 1,2,4-oxadiazolone

Country Status (27)

Country Link
US (1) US6034113A (bg)
EP (1) EP1051173A4 (bg)
JP (1) JP2002527352A (bg)
KR (1) KR20010077838A (bg)
CN (1) CN1150175C (bg)
AR (1) AR010712A1 (bg)
AU (1) AU735704B2 (bg)
BG (1) BG104706A (bg)
BR (1) BR9913010A (bg)
CA (1) CA2318830A1 (bg)
CO (1) CO5090837A1 (bg)
EE (1) EE04089B1 (bg)
GE (1) GEP20032914B (bg)
HU (1) HUP0102025A3 (bg)
ID (1) ID26909A (bg)
IL (1) IL137518A0 (bg)
LT (1) LT4838B (bg)
LV (1) LV12559B (bg)
NO (1) NO317102B1 (bg)
NZ (1) NZ505409A (bg)
PL (1) PL342060A1 (bg)
RU (1) RU2202548C2 (bg)
SK (1) SK10852000A3 (bg)
TR (1) TR200002019T2 (bg)
TW (1) TW550075B (bg)
UA (1) UA58579C2 (bg)
WO (1) WO1999038510A1 (bg)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056731A4 (en) * 1998-01-29 2002-07-31 Bristol Myers Squibb Co AMINOACID DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE
CA2358964A1 (en) * 1999-01-29 2000-08-03 Xi Chen Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US6297241B1 (en) 1999-01-29 2001-10-02 Bristol-Myers Squibb Company Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
WO2002072088A2 (en) 2001-02-20 2002-09-19 Bristol-Myers Squibb Company Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases
HUP0303829A3 (en) * 2001-04-16 2006-02-28 Tanabe Seiyaku Co Large conductance calcium-acitvated k channel opener compounds, use thereof and pharmaceutical compositions containing them
US6909027B1 (en) * 2001-08-13 2005-06-21 Perry Robins Method of forming an in-situ film dressing and the composition of the film-forming material
US7119246B2 (en) * 2002-06-25 2006-10-10 Perry Robins Method of treating acne
KR102309973B1 (ko) 2012-05-16 2021-10-06 테크필즈 파마 코., 엘티디. 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물
JP5855599B2 (ja) * 2013-04-30 2016-02-09 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
CN104710379B (zh) * 2015-03-09 2017-01-18 华南理工大学 一种bms‑191011的合成方法
JP6165816B2 (ja) * 2015-10-01 2017-07-19 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
AU2018225758A1 (en) * 2017-02-24 2019-09-05 Ovid Therapeutics Inc. Methods of treating seizure disorders
CN110987847B (zh) * 2019-12-11 2021-02-19 苏州今蓝纳米科技有限公司 1,3,4-噁二唑衍生物在检测酸以及数据加密和储存中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH583213A5 (bg) * 1973-05-21 1976-12-31 Ciba Geigy Ag
IT1251488B (it) * 1991-09-17 1995-05-15 Mini Ricerca Scient Tecnolog Ossa(tia)diazol- e triazol-oni(tioni) ad attivita' acaricida ed insetticida
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
EP1056731A4 (en) * 1998-01-29 2002-07-31 Bristol Myers Squibb Co AMINOACID DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE

Also Published As

Publication number Publication date
CO5090837A1 (es) 2001-10-30
NO317102B1 (no) 2004-08-09
TR200002019T2 (tr) 2000-11-21
PL342060A1 (en) 2001-05-21
GEP20032914B (en) 2003-03-25
KR20010077838A (ko) 2001-08-20
EE04089B1 (et) 2003-08-15
WO1999038510A1 (en) 1999-08-05
AU2230899A (en) 1999-08-16
NO20003825L (no) 2000-07-26
LV12559B (en) 2001-04-20
RU2202548C2 (ru) 2003-04-20
JP2002527352A (ja) 2002-08-27
EP1051173A4 (en) 2002-07-31
HUP0102025A3 (en) 2002-01-28
SK10852000A3 (sk) 2002-02-05
EE200000447A (et) 2001-12-17
CA2318830A1 (en) 1999-08-05
NZ505409A (en) 2003-08-29
AU735704B2 (en) 2001-07-12
HUP0102025A2 (hu) 2001-11-28
CN1289249A (zh) 2001-03-28
BG104706A (bg) 2001-04-30
AR010712A1 (es) 2000-07-12
UA58579C2 (uk) 2003-08-15
ID26909A (id) 2001-02-15
LT2000068A (en) 2001-03-26
EP1051173A1 (en) 2000-11-15
CN1150175C (zh) 2004-05-19
TW550075B (en) 2003-09-01
NO20003825D0 (no) 2000-07-26
LT4838B (lt) 2001-08-27
US6034113A (en) 2000-03-07
BR9913010A (pt) 2001-05-08
LV12559A (en) 2000-11-20

Similar Documents

Publication Publication Date Title
PL380733A1 (pl) Pochodne 3, 3-difenylopropyloamin, sposoby ich wytwarzania, ich zastosowanie medyczne oraz kompozycja farmaceutyczna
GB2319250B (en) Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
PL338563A1 (en) Substituted derivatives of 1,2,3,4-tetrahydronaphtalene
IL141226A0 (en) 1h-imidazopyridine derivatives
PT1073647E (pt) Derivados de 12,13-ciclopropano-epotilona
HK1038746A1 (en) 1,2-annelated quinoline derivatives
PL345540A1 (en) Thiobenzimidazole derivatives
HK1022310A1 (en) Benzosulfone derivatives
GB9910384D0 (en) Alpha-ketoamide derivatives
PL329121A1 (en) Substituted derivatives of 1,2,3,4-tetrahydronaphtalene
PL339137A1 (en) 6,9-bridged derivatives of erythromycin
PL340253A1 (en) 6,11-bridged derivatives of erythromycin
HU9802807D0 (en) 1,3,8-triazo-spiro[4,5]decan-4-on derivatives
PL348668A1 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
PL342060A1 (en) Derivatives of 1,3,4-oxadiaxolone
EG23802A (en) 2-Phenylpyran-4-one derivatives
IL136500A0 (en) 1,4-diazacycloheptane derivatives
GB9827729D0 (en) Thieno-indole derivatives
HUP0100841A3 (en) Glycosidation of 4,5-epoxymorphinan-6-ols
EP1061912A4 (en) PHENANTHROFURANDERIVATE
IL139276A0 (en) Cyclohexenondioxthio chromanoyl derivatives
ZA9811564B (en) Derivatives of 1,3,4-oxadiazolone
HK1042478A1 (zh) 2-氧代-2h-喹啉衍生物
PL325446A1 (en) Novel ferrocomplexes of 1:2 type - derivatives of 1,5 diphenylformazane
SI1140835T1 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives